Safety of epoietin beta-quinine drug combination in children with cerebral malaria in Mali.
about
Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcomeThe 'hidden' burden of malaria: cognitive impairment following infectionPlasmodium falciparum metacaspase PfMCA-1 triggers a z-VAD-fmk inhibitable protease to promote cell deathCerebral malaria: a vasculopathy.Diabetes mellitus: channeling care through cellular discoverySystemic and Cerebral Vascular Endothelial Growth Factor Levels Increase in Murine Cerebral Malaria along with Increased Calpain and Caspase Activity and Can be Reduced by Erythropoietin Treatment.Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malariaErythropoietin Combined with Liposomal Amphotericin B Improves Outcome during Disseminated Aspergillosis in MiceEmerging artemisinin resistance in the border areas of Thailand.Novel avenues of drug discovery and biomarkers for diabetes mellitus.The plant-based immunomodulator curcumin as a potential candidate for the development of an adjunctive therapy for cerebral malariaHigh plasma erythropoietin levels are associated with prolonged coma duration and increased mortality in children with cerebral malaria.Cytoadherence and severe malaria.Erythropoietin treatment alleviates ultrastructural myelin changes induced by murine cerebral malaria.Erythropoietin Levels Increase during Cerebral Malaria and Correlate with Heme, Interleukin-10 and Tumor Necrosis Factor-Alpha in IndiaErythropoietin and its receptors in the brainstem of adults with fatal falciparum malaria.Immunopathogenesis of falciparum malaria: implications for adjunctive therapy in the management of severe and cerebral malaria.Apoptosis induced by parasitic diseasesDo we know enough to find an adjunctive therapy for cerebral malaria in African children?Adjunctive therapy for severe malaria: a review and critical appraisal.
P2860
Q21032453-B22E5FFB-6AFE-450D-859D-1B27B9FD0CABQ21032459-6E9ADDA7-EF33-4C96-9B37-702DD415C611Q27974440-B1CB8B6D-B76F-4B35-927A-045E8675A589Q33703604-EC3224A8-3053-4CEF-A746-8FF02641A34DQ33749358-B59936AA-BEB0-4318-AAAD-EEF9F6C3AD33Q33775828-E7F6A0DB-73DD-4263-9B31-B4B3A6C0FF92Q34328743-DCB4D2B6-96D5-4B17-8E44-CB00E43DA2E3Q34336393-CADD7347-ED3E-49E6-9BB8-F6A5FD0537A3Q34343530-A11D6480-796F-4E84-B715-66BC7D91FA27Q34552287-7166978A-5D98-4048-9510-CD6412C9B272Q34687796-83F1DE40-E580-42CB-9E29-73722393A58CQ34974570-7E5852BB-E63D-45A3-BCCD-747AC7FA30D7Q36202059-63E7DFF5-3D9D-48F6-A077-697670750129Q36411555-D29AD94F-F5D0-42B0-A01E-D100CB151C24Q37115501-DDE8DA73-7450-4BAB-970D-AA1626FFDEDAQ37448745-D9714C33-360C-4413-8CB6-1A6FF0F0C7D3Q37929759-5C607AB4-4A85-4EF6-BFBA-D84D1C003C4DQ41307431-E6C836F1-ACE9-4748-9FBD-A6FB30D0A9FEQ46237821-808C13D2-683A-4EAF-82A2-A038F22D5562Q47716363-565E9134-B328-40B4-863F-920F15765E0C
P2860
Safety of epoietin beta-quinine drug combination in children with cerebral malaria in Mali.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety of epoietin beta-quinin ...... with cerebral malaria in Mali.
@en
Safety of epoietin beta-quinin ...... with cerebral malaria in Mali.
@nl
type
label
Safety of epoietin beta-quinin ...... with cerebral malaria in Mali.
@en
Safety of epoietin beta-quinin ...... with cerebral malaria in Mali.
@nl
prefLabel
Safety of epoietin beta-quinin ...... with cerebral malaria in Mali.
@en
Safety of epoietin beta-quinin ...... with cerebral malaria in Mali.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Safety of epoietin beta-quinin ...... with cerebral malaria in Mali.
@en
P2093
Anne-Lise Bienvenu
Elisabeth Diarra
Karidiatou Bamba
Salimata Konate
Sibiri Sissoko
P2860
P2888
P356
10.1186/1475-2875-8-169
P577
2009-07-24T00:00:00Z
P5875
P6179
1009748280